2don MSNOpinion
Making GLP-1 weight loss drugs cheaper isn't enough to address America's obesity problem. Here's why
The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...
A daily pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...
That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, ...
A DAILY pill that is cheaper and easier to take than currently available weight loss drugs helps people lose around a tenth ...
New Scientist on MSN
Daily pill could offer alternative to weight-loss injections
Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...
Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will patients embrace a more convenient alternative to injecting themselves, even if ...
In 2026 patents on semaglutide (the active ingredient in Wegovy and Ozempic) will expire in large emerging markets including ...
In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...
This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback